Saudi Journal of Otorhinolaryngology Head and Neck Surgery

: 2022  |  Volume : 24  |  Issue : 1  |  Page : 17--21

Basal cell carcinoma and its burden on sudanese patients

Safi Eldin E. Ali1, Hamadnalla Sir El Khatim2, Shiraz Elnur3, Saad. M Asiri4, Sami Fatehi Abdalla Billal4 
1 Sudan Medical Specialization Board, Dermatology Council, Khartoum, Sudan
2 National University, Faculty of Medicne, Department of Community, Khartoum, Sudan
3 Omdurman Dermatology Hospital, Department of Dermatology, Omdurman, Sudan
4 Faculty of Medicine, Almaarefa University, Riyadh, Saudi Arabia

Correspondence Address:
Dr. Sami Fatehi Abdalla Billal
P.O. Box 71666, Riyadh 11597
Saudi Arabia

Background: Basal cell carcinoma (BCC) is the most frequent malignant tumor in dermatology. The burden of advanced BCC is not fully understood and was not well studied in Sudan. Objective: The objectives of this work were to study the BCC disease characteristics, burden, and morbidity on a group of Sudanese patients. Patients and Methods: This is a retrospective, hospital-based study of patients' records presented to the Military Dermatology Hospital and diagnosed with BCC. The study period was 2012–2017. Results: Our team identified a total number of 27 patients to have BCC. 15 (55.6%) were males and 12 (44.4%) were females. The mean age was 54 years (with a range of 26–75 years). The site of the location of the lesions was mostly the face in 22 (81.5%), face and extremities in 4 (14.8%) patients, and in only one (3.7%) patient, it was on the abdomen. The face distribution includes the forehead (14.5%), periocular (18.5%), nose (18.5%), nose, mouth, and cheek (7.4%). The clinical presentation of the lesions includes pigmentation (70.4%), ulcers (63%), plaques (55.6%), nodules (40.7%), scars (11.1%), and deformity associated with advanced BCC in (48.2%) of the patients. The associated comorbidities were (11.1%), albinism (11.1%), and basal cell nevus syndrome (BCNS) (3.7%). Concerning the outcome and prognosis, 11 (40.7%) had a good prognosis and 16 (59.3%) had a bad prognosis. Conclusions: BCC has similar epidemiological and clinical presentation as many international studies with younger age incidence. Delay presentation results in local disease advancement and increases severity and burden. This bad burden could be attributed to inadequate health facilities.

How to cite this article:
Ali SE, El Khatim HS, Elnur S, Asiri SM, Billal SF. Basal cell carcinoma and its burden on sudanese patients.Saudi J Otorhinolaryngol Head Neck Surg 2022;24:17-21

How to cite this URL:
Ali SE, El Khatim HS, Elnur S, Asiri SM, Billal SF. Basal cell carcinoma and its burden on sudanese patients. Saudi J Otorhinolaryngol Head Neck Surg [serial online] 2022 [cited 2022 Aug 10 ];24:17-21
Available from:;year=2022;volume=24;issue=1;spage=17;epage=21;aulast=Ali;type=0